Fourth-quarter net revenues and earnings of FUL are hurt by weaker-than-expected conditions and delayed orders.
H.B. Fuller Company (NYSE:FUL ) Q3 2024 Earnings Conference Call September 26, 2024 10:30 AM ET Company Participants Steven Brazones - Vice President, Investor Relations Celeste Mastin - President & Chief Executive Officer John Corkrean - Executive Vice President & Chief Financial Executive Conference Call Participants Patrick Cunningham - Citi Kevin McCarthy - Vertical Research Partners Mike Harrison - Seaport Research Partners David Begleiter - Deutsche Bank Jeff Zekauskas - JPMorgan Matt Krueger - Baird Operator Thank you for standing by, and welcome to the H.B. Fuller Third Quarter 2024 Earnings Conference Call.
While the top- and bottom-line numbers for H. B. Fuller (FUL) give a sense of how the business performed in the quarter ended August 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
H. B. Fuller (FUL) came out with quarterly earnings of $1.13 per share, missing the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.06 per share a year ago.
Evaluate the expected performance of H. B. Fuller (FUL) for the quarter ended August 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Investors interested in stocks from the Chemical - Specialty sector have probably already heard of H. B. Fuller (FUL) and Novozymes A/S (NVZMY).
Investors with an interest in Chemical - Specialty stocks have likely encountered both H. B. Fuller (FUL) and CSW Industrials (CSWI).
Investors interested in Chemical - Specialty stocks are likely familiar with H. B. Fuller (FUL) and Hawkins (HWKN).
Investors looking for stocks in the Chemical - Specialty sector might want to consider either H. B. Fuller (FUL) or Hawkins (HWKN).
Today we show investors how to screen for stocks that offer the potentially winning combination of impressive value and improving earnings outlooks to buy in July and beyond.
H.B. Fuller (FUL) presents a substantial investment opportunity with robust earnings outperformance and promising growth prospects.
H.B. Fuller's (FUL) second-quarter earnings and sales top estimates on higher gross margins and volumes.